Meta-analysis of peripheral insulin-like growth factor 1 levels in schizophrenia.

Ana V PejcicSlobodan M JankovicVladimir JanjicMilan DjordjicJovana Z MilosavljevicMilos N Milosavljevic

Published in: Brain and behavior (2022)

Schizophrenia patients under antipsychotic treatment seem to have lower peripheral IGF-1 levels compared to healthy controls. Additional studies with larger and more homogenous samples are needed to confirm these findings.

Keyphrases

bipolar disorder
systematic review
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
signaling pathway
growth hormone
pi k akt